The PE-Backed Sponsor IPO Backlog and What's Driving It

Introduction

The PE-backed IPO backlog is the queue of sponsor-owned companies that could not exit on schedule during the 2022-2024 drought. On WilmerHale's count of US issuers, PE-backed IPOs doubled to 24 in 2025 from 12 in 2024. On Dealogic's count, 21 PE-backed companies had listed in the US by August 5, 2026, already above Dealogic's 20 for all of 2025 and the fastest pace since 2021 (the providers define the cohort differently, so each comparison stays within one series). The 2020-2021 vintage cohort drives the queue, and LP distribution pressure pushes sponsors toward listings that might once have been sales. This article covers the drivers, the marker deals, and the ECM mechanics that turn a listing into an exit; route-by-route exit data sits in sponsor exit trends by route.

Multiple converging factors created the 2025-2026 sponsor IPO backlog.

The 2020-2021 Vintage Cohort

PE funds that deployed capital in 2020 and 2021 (the COVID-era peak) underwrote at peak valuations with 5-to-6-year hold assumptions, implying 2025-2027 exits. Multiple compression and the 2022-2024 drought delayed monetization, leaving an aging cohort that now needs liquidity.

Vintage Portfolio Aging

The process by which PE fund vintages (investments made in a given year) approach the exit windows implied by their underwritten hold periods, typically 5-6 years. The 2022-2024 exit drought pushed most 2020-2021 vintage assets past that timing, creating the multi-year backlog behind 2025-2026 IPO and M&A exits and the LP pressure to return capital.

The Pace of Exit Mismatch

Historical PE exit data shows GPs typically sold 30 percent of investments by year four (2011-2020 baseline). The 2021 vintage cohort had sold only 19 percent of acquisitions by 2025, an 11-percentage-point shortfall whose unrealized exposure is the principal source of the current sponsor IPO backlog.

LP Distribution Pressure

PE sponsors face mounting LP pressure to return capital. Through the exit drought, limited partners received far less cash than fund lives implied, and DPI, the distribution clock LPs now watch, has made distributions a principal driver of sponsor exit timing.

Lower Rates and Improving Equity Multiples

Fed cuts that resumed in September 2025 and the equity-market multiple recovery opened the window the backlog needed, producing the 2025 sponsor IPO rebound. The link runs both ways: when the FOMC raised its target range to 3.75-4.00% on September 16, 2026, the fall pickup stalled.

Several 2025 sponsor-backed IPOs signaled the backlog was reopening, the latest stage in a multi-year arc.

Medline: The Year's Marquee PE-Backed Exit

Blackstone, Carlyle, and Hellman & Friedman took Medline (medical-surgical product provider) public in 2025's largest PE-backed IPO, raising $6.26 billion. Medline had been taken private in 2021 in a $34 billion sponsor-led transaction; the IPO began a staged public-market sell-down after a four-year hold, with all three sponsors keeping large stakes.

Liftoff and the Mobile Advertising Pattern

Blackstone-backed Liftoff pulled an earlier attempt, then raised about $437 million in June 2026 at $23 a share, a valuation of about $3.83 billion, with proceeds earmarked to repay term-loan debt. That right-sized second attempt is the playbook for a reluctant window: a smaller deal, a lower valuation, and primary proceeds that deleverage the company before the sponsor sells.

The 2025 PE-Backed Cohort

Beyond Medline, the 2025 PE-backed IPO cohort mixed healthcare, technology, consumer, and industrial issuers; its standout, Blackstone-backed Legence, funded the sell-downs described below.

Pre-IPO sponsors holding pass-through entities (LLCs taxed as partnerships) frequently use the Up-C (Umbrella Partnership C-Corp) structure to capture the IPO's tax efficiency advantages. The structure has been used by 50-plus US IPOs over the past five years including GoDaddy, Bumble, Shoals, and Legence in 2025.

Up-C Mechanics

Pre-IPO partnership owners form a new C-corporation holding company (PubCo) with no material assets other than its equity in the existing operating partnership (OpCo). PubCo issues Class A common stock to public investors (most economic rights, small voting share) and Class B to pre-IPO investors (voting only, with economics through OpCo units). Pre-IPO owners exchange OpCo units for PubCo shares over time, generating step-ups in the tax basis of OpCo's assets that produce future tax deductions for PubCo.

Tax Receivable Agreement Economics

The Up-C is paired with a Tax Receivable Agreement (TRA) that requires PubCo to pay 85 percent of the actual tax savings produced by the basis step-ups back to the pre-IPO owners over time (the market-standard split), retaining the remaining 15 percent. TRA payment streams typically run 15 years and represent material ongoing economics: GoDaddy's TRA nominal liability was disclosed at approximately $1.8 billion over the contract life (the company ultimately paid $850 million to terminate the TRA early in 2020). For the sponsor, the TRA is a second monetization stream alongside the shares it sells in the IPO and later sell-downs.

An IPO competes with sales to strategics, secondary buyouts, and continuation vehicles (about 14% of sponsor-backed exit volume in 2025 on Jefferies' measure); the route-by-route exit trends cover that mix. For ECM, the question is how a listing beats those bids and then turns into cash.

Dual-Track and Triple-Track Processes

Dual-track processes run a sale and an IPO in parallel, and the triple track adds a continuation vehicle, so each path sets a price floor for the others. Sponsors kept running them in 2026: as Deutsche Bank's Nick Williams told ION Analytics in October, "You cannot sell everything to a strategic." Running an IPO and M&A in parallel and the modern triple track cover the mechanics.

Sell-Downs and Lockups After the Listing

A listing usually sells a minority stake, so the sponsor's exit runs through follow-on sell-downs once the lockup (typically 180 days) expires or the underwriters waive it. Blackstone took Legence, a 2020 buyout, public on Nasdaq in September 2025 at $28 a share, then sold through upsized secondaries at $45 in December 2025 and $54 in April 2026, in which Legence received no proceeds. Aftermarket performance prices every later tranche, so it can matter more to the sponsor than the IPO price; sponsor secondary offerings and lockup expiration cover the mechanics.

Sponsor leaders called 2026 early, and the year has tested the call.

Blackstone, KKR, Apollo Forecasts

Blackstone President Jon Gray told the WSJ Invest conference in February that "2026 should be the year of the IPO," and KKR, Apollo, and TPG each previewed multiple exits. By dollars he was right: Renaissance Capital's quarterly data put US IPO proceeds at about $147.5 billion in the first nine months, above 2021's full-year record of $142.4 billion, led by two mega-deals outside the buyout backlog: SpaceX's $75 billion June listing (before the over-allotment) and SK hynix's $26.5 billion July US offering. The sponsor cohort was strong but not dominant: private equity backed 22 IPOs in the second quarter, its busiest since 2021, yet Renaissance's PE-backed tally raised only about $22 billion over nine months excluding SK hynix (which it counts as PE-backed), under a third of SpaceX alone.

Specific 2026 Pipeline and Aggregate Realization

The calendar cleared part of the queue. Blackstone took Jersey Mike's public on July 29 at $23, the range midpoint, raising $1.0 billion at a $7.3 billion value; selling shareholders supplied 29.7 million of the 43.5 million shares, a secondary-heavy IPO that starts the exit on day one. Others slipped: Copeland (Blackstone) is a possible year-end deal, Thoma Bravo's Proofpoint and Hellman & Friedman's Genesys look likelier for 2027, and Hg-backed Visma pushed its London listing to 2027 as other European sponsor processes slid toward late 2026 or 2027.

Risk: Selective Investor Reception

Investors stayed selective. Renaissance data reported by Moonfare had the year's PE-backed IPOs about 21% above issue in early June, but Renaissance's third-quarter review put that quarter's PE-backed IPOs an average 9% below offer (15% excluding SK hynix), with five of seven under issue and Jersey Mike's 27% below its IPO price. The fall stall compounded it: the September 16 Fed hike, a 19-year high in bond yields, and the approaching midterms produced quarter-end postponements, including CVC-backed Bamboo Insurance. Dealogic still counted 23 North American sponsor-backed IPOs worth $21.5 billion through September 29, against 14 worth $8.2 billion a year earlier, but ION Analytics reports sponsors would rather delay than sacrifice value, and Dealogic expects the window to reopen after the midterms. Issuers without premium-quality fundamentals face the hardest test.

The PE-backed sponsor IPO backlog above is one of the structural drivers of 2025-2026 ECM activity. The next article walks through the 2026 convertible record, where AI capex turned equity-linked issuance into the year's other record-setting market.